ConductScience.org, home

Gene · 3360

Drugs25

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
AMISULPRIDECHEMBL243712Serotonin (5-HT) receptor antagonistANTAGONISTChEMBL
CAPESERODCHEMBL2027925Serotonin 4 (5-HT4) receptor partial agonistPARTIAL AGONISTChEMBL
CISAPRIDECHEMBL1729Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
CISAPRIDE MONOHYDRATECHEMBL1200788Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
CLEBOPRIDECHEMBL325109Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
DEXFENFLURAMINECHEMBL248702Serotonin (5-HT) receptor agonistAGONISTChEMBL
DEXFENFLURAMINE HYDROCHLORIDECHEMBL1887891Serotonin (5-HT) receptor agonistAGONISTChEMBL
FELCISETRAGCHEMBL2402904Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
LEVOSULPIRIDECHEMBL267044Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
METOCLOPRAMIDECHEMBL86Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
METOCLOPRAMIDE HYDROCHLORIDECHEMBL1200940Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
MOSAPRIDECHEMBL60889Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
NARONAPRIDECHEMBL2103858Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
PIBOSERODCHEMBL356359Serotonin 4 (5-HT4) receptor antagonistANTAGONISTChEMBL
PRUCALOPRIDECHEMBL117287Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
PRUCALOPRIDE SUCCINATECHEMBL2105748Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
PRX-03140CHEMBL3306918Serotonin 4 (5-HT4) receptor partial agonistPARTIAL AGONISTChEMBL
RELENOPRIDECHEMBL3544975Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
RENZAPRIDECHEMBL296522Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL
REVEXEPRIDECHEMBL3545035Serotonin 4 (5-HT4) receptor agonistAGONISTChEMBL

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3360/drugs